David Kylhammar
Overview
Explore the profile of David Kylhammar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
405
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kylhammar D, Nilsson F, Dyverfeldt P, Hammareus F, Jonasson L, Trzebiatowska-Krzynska A, et al.
Heart
. 2025 Mar;
PMID: 40081936
Background: Thoracic aortic aneurysm is a life-threatening disease due to the risk for acute aortic syndromes, and subjects with dilated ascending aortas are recommended surveillance imaging to assess the need...
2.
Wang A, Ostgren C, Norhammar A, Kylhammar D, Jernberg T, Lind L, et al.
Cardiovasc Diabetol
. 2025 Mar;
24(1):105.
PMID: 40045270
Background: Aortic valve calcification (AVC) is an underlying pathophysiological mechanism in aortic stenosis, which shares many risk factors with diabetes. However, the association between dysglycemia and early stages of AVC...
3.
Blomberg A, Toren K, Liv P, Granasen G, Andersson A, Behndig A, et al.
Ann Am Thorac Soc
. 2024 Aug;
21(12):1678-1687.
PMID: 39133529
Chronic obstructive pulmonary disease (COPD) includes respiratory symptoms and chronic airflow limitation (CAL). In some cases, emphysema and impaired diffusing capacity of the lung for carbon monoxide (Dl) are present,...
4.
Toren K, Blomberg A, Schioler L, Malinovschi A, Backman H, Caidahl K, et al.
Ann Am Thorac Soc
. 2024 Jul;
21(11):1524-1532.
PMID: 39079106
Knowledge regarding the prevalence and shared and unique characteristics of the restrictive spirometric pattern (RSP) and preserved ratio impaired spirometry (PRISm) is lacking for a general population investigated with post-bronchodilator...
5.
Hammareus F, Trenti C, Bjorck H, Engvall J, Lekedal H, Krzynska-Trzebiatowska A, et al.
Eur Heart J Cardiovasc Imaging
. 2024 May;
25(10):1384-1393.
PMID: 38748858
Aims: Understanding the mechanisms underlying ascending aortic dilation is imperative for refined risk stratification of these patients, particularly among incidentally identified patients, most commonly presenting with tricuspid valves. The aim...
6.
Ostgren C, Otten J, Festin K, Angeras O, Bergstrom G, Cederlund K, et al.
Cardiovasc Diabetol
. 2023 Sep;
22(1):261.
PMID: 37759237
Background: Patients with type 2 diabetes have an increased risk of death and cardiovascular events and people with diabetes or prediabetes have been found to have increased atherosclerotic burden in...
7.
Malinovschi A, Zhou X, Andersson A, Backman H, Bake B, Blomberg A, et al.
Am J Respir Crit Care Med
. 2023 Jun;
208(4):461-471.
PMID: 37339507
Postbronchodilator spirometry is used for the diagnosis of chronic obstructive pulmonary disease. However, prebronchodilator reference values are used for spirometry interpretation. To compare the resulting prevalence rates of abnormal spirometry...
8.
Hjalmarsson C, Kjellstrom B, Jansson K, Nisell M, Kylhammar D, Kavianipour M, et al.
ERJ Open Res
. 2021 Aug;
7(3).
PMID: 34350280
Despite systematic screening and improved treatment strategies, the prognosis remains worse in patients with connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) compared to patients with idiopathic/hereditary pulmonary arterial hypertension (IPAH)....
9.
Kylhammar D, Hjalmarsson C, Hesselstrand R, Jansson K, Kavianipour M, Kjellstrom B, et al.
ERJ Open Res
. 2021 Jun;
7(2).
PMID: 34084789
The European Society of Cardiology (ESC) and European Respiratory Society (ERS) guideline recommendation of comprehensive risk assessments, which classify patients with pulmonary arterial hypertension (PAH) as having low, intermediate or...
10.
Toren K, Schioler L, Lindberg A, Andersson A, Behndig A, Bergstrom G, et al.
Clin Physiol Funct Imaging
. 2020 Dec;
41(2):181-191.
PMID: 33284499
Chronic airflow limitation (CAL) can be defined as fixed ratio of forced expiratory volume in 1 s (FEV )/forced vital capacity (FVC) < 0.70 after bronchodilation. It is unclear which...